On the public citation graph
Minimal Change Disease
0 signed · 694 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archinte.137.7.891openalex-snapshot
Prognosis in steroid-treated idiopathic nephrotic syndrome in adults. Analysis of major predictive factors after ten-year follow-up
inferredcites →https://doi.org/10.1001/archinte.146.4.737openalex-snapshot
Effect of Long-term Azathioprine Administration in Adults With Minimal-Change Glomerulonephritis and Nephrotic Syndrome Resistant to Corticosteroids
inferredcites →https://doi.org/10.1002/14651858.cd001533.pub5openalex-snapshot
Corticosteroid therapy for nephrotic syndrome in children
inferredcites →https://doi.org/10.1002/14651858.cd001537.pub4openalex-snapshot
Interventions for minimal change disease in adults with nephrotic syndrome
inferredcites →https://doi.org/10.1002/14651858.cd002290.pub4openalex-snapshot
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children
inferredcites →https://doi.org/10.1002/14651858.cd002290.pub5openalex-snapshot
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children
inferredcites →https://doi.org/10.1002/14651858.cd003594.pub5openalex-snapshot
Interventions for idiopathic steroid-resistant nephrotic syndrome in children
inferredcites →https://doi.org/10.1002/1529-0131(200107)44:7<1496::aid-art271>3.0.co;2-5openalex-snapshot
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update
inferredcites →https://doi.org/10.1002/art.1780391104openalex-snapshot
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
inferredcites →https://doi.org/10.1007/bf00442096openalex-snapshot
Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome
inferredcites →https://doi.org/10.1007/bf00856511openalex-snapshot
Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood
inferredcites →https://doi.org/10.1007/bf01956754openalex-snapshot
Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children
inferredcites →https://doi.org/10.1007/s00011-013-0672-6openalex-snapshot
The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies
inferredcites →https://doi.org/10.1007/s00281-013-0415-3openalex-snapshot
Immunopathogenesis of idiopathic nephrotic syndrome with relapse
inferredcites →https://doi.org/10.1007/s00467-003-1175-4openalex-snapshot
Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome
inferredcites →https://doi.org/10.1007/s00467-003-1176-3openalex-snapshot
Long-term linear growth of children with severe steroid-responsive nephrotic syndrome
inferredcites →https://doi.org/10.1007/s00467-004-1615-9openalex-snapshot
Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise?
inferredcites →https://doi.org/10.1007/s00467-005-1877-xopenalex-snapshot
Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome
inferredcites →https://doi.org/10.1007/s00467-005-1968-8openalex-snapshot
Evidence-based management of steroid-sensitive nephrotic syndrome
inferredcites →https://doi.org/10.1007/s00467-009-1119-8openalex-snapshot
Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
inferredcites →https://doi.org/10.1007/s00467-011-1947-1openalex-snapshot
Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives
inferredcites →https://doi.org/10.1007/s00467-012-2228-3openalex-snapshot
Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome
inferredcites →https://doi.org/10.1007/s00467-012-2310-xopenalex-snapshot
Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO
inferredcites →https://doi.org/10.1007/s00467-012-2406-3openalex-snapshot
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome
inferredcites →https://doi.org/10.1007/s00467-015-3219-yopenalex-snapshot
Vaccinations in children on immunosuppressive medications for renal disease
inferredcites →https://doi.org/10.1007/s00467-015-3241-0openalex-snapshot
The non-immunosuppressive management of childhood nephrotic syndrome
inferredcites →https://doi.org/10.1007/s00467-015-3245-9openalex-snapshot
Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome
inferredcites →https://doi.org/10.1007/s004670050558openalex-snapshot
Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome
inferredcites →https://doi.org/10.1007/s004670050708openalex-snapshot
Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome
inferredcites →https://doi.org/10.1016/0002-9343(88)90580-3openalex-snapshot
Treatment of proteinuric idiopathic glomerulonephritides in adults: A retrospective survey
inferredcites →https://doi.org/10.1016/b978-0-323-04883-5.50018-0openalex-snapshot
Nephrotic Syndrome
inferredcites →https://doi.org/10.1016/b978-1-4160-6640-8.00011-7openalex-snapshot
Primary Glomerular Disease
inferredcites →https://doi.org/10.1016/j.clim.2011.02.018openalex-snapshot
Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome
inferredcites →https://doi.org/10.1016/j.clinthera.2012.03.008openalex-snapshot
Tacrolimus Versus Intravenous Pulse Cyclophosphamide Therapy in Chinese Adults With Steroid-Resistant Idiopathic Minimal Change Nephropathy: A Multicenter, Open-Label, Nonrandomized Cohort Trial
inferredcites →https://doi.org/10.1016/j.jpeds.2005.03.050openalex-snapshot
Children with Steroid-sensitive Nephrotic Syndrome Come of Age: Long-term Outcome
inferredcites →https://doi.org/10.1016/j.jpeds.2009.12.020openalex-snapshot
Time for Initial Response to Steroids Is a Major Prognostic Factor in Idiopathic Nephrotic Syndrome
inferredcites →https://doi.org/10.1016/s0022-3476(73)80585-2openalex-snapshot
A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood
inferredcites →https://doi.org/10.1016/s0022-3476(79)80658-7openalex-snapshot
Nephrotic syndrome in children: A randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early
inferredcites →https://doi.org/10.1016/s0022-3476(79)80660-5openalex-snapshot
Focal glomerulosclerosis and renal transplantation
inferredcites →https://doi.org/10.1016/s0022-3476(81)80760-3openalex-snapshot
The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone
inferredcites →https://doi.org/10.1016/s0022-3476(88)80136-7openalex-snapshot
Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome
inferredcites →https://doi.org/10.1016/s0140-6736(03)14184-0openalex-snapshot
Nephrotic syndrome in childhood
inferredcites →https://doi.org/10.1016/s0140-6736(16)00272-5openalex-snapshot
Primary glomerulonephritides
inferredcites →https://doi.org/10.1016/s0140-6736(70)90108-xopenalex-snapshot
CONTROLLED TRIAL OF CYCLOPHOSPHAMIDE IN STEROID-SENSITIVE RELAPSING NEPHROTIC SYNDROME OF CHILDHOOD
inferredcites →https://doi.org/10.1016/s0140-6736(70)91093-7openalex-snapshot
CONTROLLED TRIAL OF AZATHIOPRINE IN CHILDREN WITH NEPHROTIC SYNDROME
inferredcites →https://doi.org/10.1016/s0140-6736(74)91880-7openalex-snapshot
PATHOGENESIS OF LIPOID NEPHROSIS: A DISORDER OF T-CELL FUNCTION
inferredcites →https://doi.org/10.1016/s0140-6736(88)91182-8openalex-snapshot
SHORT VERSUS STANDARD PREDNISONE THERAPY FOR INITIAL TREATMENT OF IDIOPATHIC NEPHROTIC SYNDROME IN CHILDREN
inferredcites →https://doi.org/10.1016/s0272-6386(12)80353-2openalex-snapshot
Minimal Change Nephrotic Syndrome in Adults: Response to Corticosteroid Therapy and Frequency of Relapse
inferredcites →https://doi.org/10.1016/s0272-6386(84)80043-8openalex-snapshot
The Clinical Significance of Mesangial IgM Deposits and Mesangial Hypercellularity in Minimal Change Nephrotic Syndrome
inferredcites →https://doi.org/10.1016/s0272-6386(87)80170-1openalex-snapshot
The Nephrotic Syndrome and Its Complications
inferredcites →https://doi.org/10.1038/ki.1985.153openalex-snapshot
Glomerular sieving of anionic and neutral bovine albumins in proteinuric rats
inferredcites →https://doi.org/10.1038/ki.1986.130openalex-snapshot
Adult–onset minimal change nephrotic syndrome: A long–term follow–up
inferredcites →https://doi.org/10.1038/ki.1990.175openalex-snapshot
Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis
inferredcites →https://doi.org/10.1038/ki.1991.232openalex-snapshot
A glomerular permeability factor produced by human T cell hybridomas
inferredcites →https://doi.org/10.1038/ki.1993.194openalex-snapshot
A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome
inferredcites →https://doi.org/10.1038/ki.1994.189openalex-snapshot
Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome
inferredcites →https://doi.org/10.1038/ki.1994.311openalex-snapshot
Treatment of the nephrotic syndrome associated with primary glomerulonephritis
inferredcites →https://doi.org/10.1038/ki.2010.143openalex-snapshot
Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis
inferredcites →https://doi.org/10.1038/ki.2013.93openalex-snapshot
Genetic screening in adolescents with steroid-resistant nephrotic syndrome
inferredcites →https://doi.org/10.1038/kisup.2012.9openalex-snapshot
Shortened red blood cell survival in uremic patients: beneficial and deleterious effects of dialysis.
inferredcites →https://doi.org/10.1038/nm.1857openalex-snapshot
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
inferredcites →https://doi.org/10.1038/nm.2261openalex-snapshot
Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome
inferredcites →https://doi.org/10.1038/nrneph.2013.153openalex-snapshot
Rituximab in childhood steroid-dependent nephrotic syndrome
inferredcites →https://doi.org/10.1042/cs20040095openalex-snapshot
Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome
inferredcites →https://doi.org/10.1046/j.1523-1755.2001.00577.xopenalex-snapshot
Role of CD8+ cells in the progression of murine adriamycin nephropathy
inferredcites →https://doi.org/10.1046/j.1523-1755.2002.00214.xopenalex-snapshot
Mycophenolate mofetil treatment for primary glomerular diseases
inferredcites →https://doi.org/10.1053/ajkd.1998.v31.pm9631836openalex-snapshot
Follow-up study of children with nephrotic syndrome treated with a long- term moderate dose of cyclosporine
inferredcites →https://doi.org/10.1053/ajkd.2002.31400openalex-snapshot
Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome
inferredcites →https://doi.org/10.1053/ajkd.2003.50116openalex-snapshot
Steroid-sensitive nephrotic syndrome: From childhood to adulthood
inferredcites →https://doi.org/10.1053/j.ajkd.2003.08.011openalex-snapshot
Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome
inferredcites →https://doi.org/10.1053/j.ajkd.2003.10.030openalex-snapshot
A case of langerhans’-cell histiocytosis with membranous nephropathy
inferredcites →https://doi.org/10.1053/j.ajkd.2003.11.015openalex-snapshot
Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy
inferredcites →https://doi.org/10.1053/j.ajkd.2005.02.007openalex-snapshot
Increased Endothelin 1 Expression in Adult-Onset Minimal Change Nephropathy With Acute Renal Failure
inferredcites →https://doi.org/10.1053/j.ajkd.2006.10.015openalex-snapshot
Unexpected Efficacy of Rituximab in Multirelapsing Minimal Change Nephrotic Syndrome in the Adult: First Case Report and Pathophysiological Considerations
inferredcites →https://doi.org/10.1053/j.ajkd.2007.02.270openalex-snapshot
Long-Term Outcome After Cyclophosphamide Treatment in Children With Steroid-Dependent and Frequently Relapsing Minimal Change Nephrotic Syndrome
inferredcites →https://doi.org/10.1053/j.ajkd.2008.11.033openalex-snapshot
Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial
inferredcites →https://doi.org/10.1056/nejm197609302951402openalex-snapshot
Chlorambucil Treatment of Frequently Relapsing Nephrotic Syndrome
inferredcites →https://doi.org/10.1056/nejm198004243021701openalex-snapshot
Long-Term Evaluation of Chlorambucil plus Prednisone in the Idiopathic Nephrotic Syndrome of Childhood
inferredcites →https://doi.org/10.1056/nejm198202253060803openalex-snapshot
Effect of Cytotoxic Drugs in Frequently Relapsing Nephrotic Syndrome with and without Steroid Dependence
inferredcites →https://doi.org/10.1056/nejmc1308488openalex-snapshot
Ofatumumab for Rituximab-Resistant Nephrotic Syndrome
inferredcites →https://doi.org/10.1056/nejmra1106556openalex-snapshot
Focal Segmental Glomerulosclerosis
inferredcites →https://doi.org/10.1084/jem.106.5.649openalex-snapshot
AN ELECTRON MICROSCOPE STUDY OF THE GLOMERULUS IN NEPHROSIS, GLOMERULONEPHRITIS, AND LUPUS ERYTHEMATOSUS
inferredcites →https://doi.org/10.1093/joneph/21.1.127openalex-snapshot
The use of enteric-coated mycophenolate sodium in the treatment of relapsing and steroid-dependent minimal change disease
inferredcites →https://doi.org/10.1093/ndt/11.11.2192openalex-snapshot
Long-term outcome of adult-onset minimal-change nephropathy
inferredcites →https://doi.org/10.1093/ndt/8.12.1326openalex-snapshot
Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial
inferredcites →https://doi.org/10.1093/ndt/gfg1067openalex-snapshot
Treatment of idiopathic nephrosis by immunophillin modulation
inferredcites →https://doi.org/10.1093/ndt/gfi059openalex-snapshot
Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience
inferredcites →https://doi.org/10.1093/ndt/gfi274openalex-snapshot
Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus
inferredcites →https://doi.org/10.1093/ndt/gfm092openalex-snapshot
Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated
inferredcites →https://doi.org/10.1093/ndt/gfm637openalex-snapshot
Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome
inferredcites →https://doi.org/10.1093/ndt/gfp422openalex-snapshot
Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome
inferredcites →https://doi.org/10.1093/ndt/gfr405openalex-snapshot
Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery
inferredcites →https://doi.org/10.1093/ndt/gfr572openalex-snapshot
Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome
inferredcites →https://doi.org/10.1093/ndt/gfu355openalex-snapshot
Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future
inferredcites →https://doi.org/10.1093/ndt/gfu368openalex-snapshot
Inhibition of the VEGF signalling pathway and glomerular disorders
inferredcites →https://doi.org/10.1093/oxfordjournals.ndt.a027136openalex-snapshot
Long-term outcome of adult-onset minimal-change nephropathy
inferredcites →https://doi.org/10.1093/oxfordjournals.qjmed.a067724openalex-snapshot
Minimal Change Glomerular Disease in Malaysian Adults and use of Alternate Day Steroid Therapy
inferredcites →https://doi.org/10.1111/cei.12675openalex-snapshot
Regulatory T cells and minimal change nephropathy: in the midst of a complex network
inferredcites →https://doi.org/10.1111/j.1523-1755.2005.00664.xopenalex-snapshot
Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats
inferredcites →https://doi.org/10.1111/nep.12590openalex-snapshot
Corticosteroid therapy for nephrotic syndrome in children
inferredcites →https://doi.org/10.1126/scitranslmed.3002231openalex-snapshot
Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis
inferredcites →https://doi.org/10.1136/adc.65.10.1147openalex-snapshot
Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.
inferredcites →https://doi.org/10.1136/bmj.291.6505.1305openalex-snapshot
Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome.
inferredcites →https://doi.org/10.1136/bmj.3.5720.421openalex-snapshot
Controlled Trial of Prednisone in Adult Patients with the Nephrotic Syndrome
inferredcites →https://doi.org/10.1136/bmj.4.5726.7openalex-snapshot
Membranoproliferative Glomerulonephritis and Persistent Hypocomplementaemia
inferredcites →https://doi.org/10.1136/bmj.4.5935.7openalex-snapshot
Long-term Stability of Remission in Nephrotic Syndrome after Treatment with Cyclophosphamide
inferredcites →https://doi.org/10.1159/000167603openalex-snapshot
Minimal-Change Glomerulopathy of Adulthood
inferredcites →https://doi.org/10.1159/000168656openalex-snapshot
Therapy of Idiopathic Nephrotic Syndrome in Adults
inferredcites →https://doi.org/10.1159/000184494openalex-snapshot
Minimal-Change Nephrotic Syndrome in Adults Treated with Alternate-Day Steroids
inferredcites →https://doi.org/10.1159/000186990openalex-snapshot
Inhibition of Vascular Permeability Factor Production by Ciclosporin in Minimal Change Nephrotic Syndrome
inferredcites →https://doi.org/10.1159/000187855openalex-snapshot
Use of Levamisole in Maintaining Remission in Steroid-Sensitive Nephrotic Syndrome in Children
inferredcites →https://doi.org/10.1172/jci116831openalex-snapshot
Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans.
inferredcites →https://doi.org/10.1542/peds.105.6.1242openalex-snapshot
Evaluation and Management of Proteinuria and Nephrotic Syndrome in Children: Recommendations From a Pediatric Nephrology Panel Established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE)
inferredcites →https://doi.org/10.1681/asn.2005090922openalex-snapshot
Initial Treatment of Idiopathic Nephrotic Syndrome in Children
inferredcites →https://doi.org/10.1681/asn.2006070710openalex-snapshot
Overexpression of Interleukin-13 Induces Minimal-Change–Like Nephropathy in Rats
inferredcites →https://doi.org/10.1681/asn.2007080940openalex-snapshot
Hemopexin Induces Nephrin-Dependent Reorganization of the Actin Cytoskeleton in Podocytes
inferredcites →https://doi.org/10.1681/asn.2011080775openalex-snapshot
Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome
inferredcites →https://doi.org/10.1681/asn.2012070734openalex-snapshot
The Treatment of Minimal Change Disease in Adults
inferredcites →https://doi.org/10.1681/asn.2012121200openalex-snapshot
Mycophenolate Mofetil versus Cyclosporin A in Children with Frequently Relapsing Nephrotic Syndrome
inferredcites →https://doi.org/10.1681/asn.2013030251openalex-snapshot
Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome
inferredcites →https://doi.org/10.1681/asn.2013080852openalex-snapshot
Initial Steroid Sensitivity in Children with Steroid-Resistant Nephrotic Syndrome Predicts Post-Transplant Recurrence
inferredcites →https://doi.org/10.1681/asn.2014050489openalex-snapshot
A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome
inferredcites →https://doi.org/10.1681/asn.2014070640openalex-snapshot
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy
inferredcites →https://doi.org/10.1681/asn.2015050523openalex-snapshot
B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome
inferredcites →https://doi.org/10.1681/asn.2015091002openalex-snapshot
B7–1 Blockade Does Not Improve Post–Transplant Nephrotic Syndrome Caused by Recurrent FSGS
inferredcites →https://doi.org/10.1681/asn.v481571openalex-snapshot
Determinants of glomerular hypofiltration in nephrotic patients with minimal change nephropathy.
inferredcites →https://doi.org/10.1681/asn.v74543openalex-snapshot
Long-term cyclosporine therapy for pediatric nephrotic syndrome
inferredcites →https://doi.org/10.1681/asn.v85769openalex-snapshot
Prognostic significance of the early course of minimal change nephrotic syndrome
inferredcites →https://doi.org/10.2215/cjn.01520209openalex-snapshot
Risk Factors for Cyclosporin A Nephrotoxicity in Children with Steroid-Dependant Nephrotic Syndrome
inferredcites →https://doi.org/10.2215/cjn.03470410openalex-snapshot
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
inferredcites →https://doi.org/10.2215/cjn.06620615openalex-snapshot
AKI in Children Hospitalized with Nephrotic Syndrome
inferredcites →https://doi.org/10.2215/cjn.07370715openalex-snapshot
Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid–Resistant Nephrotic Syndrome
inferredcites →https://doi.org/10.2215/cjn.08500815openalex-snapshot
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children
inferredcites →https://doi.org/10.2215/cjn.10131011openalex-snapshot
Epidemiology and Pathophysiology of Nephrotic Syndrome–Associated Thromboembolic Disease
inferredcites →https://doi.org/10.2215/cjn.11951113openalex-snapshot
IgA Nephropathy with Minimal Change Disease
inferredcites →https://doi.org/10.3389/fped.2015.00078openalex-snapshot
The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome
inferredcites →https://doi.org/10.3389/fped.2016.00032openalex-snapshot
Pathology of Podocytopathies Causing Nephrotic Syndrome in Children
inferredcites →https://doi.org/10.4103/0971-4065.53321openalex-snapshot
Ponticelli regimen in idiopathic nephrotic syndrome
inferredcites →https://doi.org/10.4239/wjd.v6.i3.445openalex-snapshot
New-onset diabetes mellitus after kidney transplantation: Current status and future directions
inferredcites →https://doi.org/10.5414/cnp65393openalex-snapshot
Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3987062openalex-extracted
How to Quantify Podocytopenia in the Clinical Practice? A New Step in Computational Renal Pathology
inferred← citeshttps://doi.org/10.2139/ssrn.4189329openalex-extracted
Minnelide Combined with Angptl3 Knockout Completely Protects Mice with Adriamycin Nephropathy Via Suppression of TGF-β1-Smad2 and p53 Pathways
inferred← citeshttps://doi.org/10.1002/14651858.cd001533.pub6openalex-snapshot
Corticosteroid therapy for nephrotic syndrome in children
inferred← citeshttps://doi.org/10.1002/14651858.cd001537.pub4openalex-snapshot
Interventions for minimal change disease in adults with nephrotic syndrome
inferred← citeshttps://doi.org/10.1002/14651858.cd001537.pub5openalex-snapshot
Interventions for minimal change disease in adults with nephrotic syndrome
inferred← citeshttps://doi.org/10.1002/14651858.cd006335.pub3openalex-snapshot
Chinese herbal medicine Huangqi type formulations for nephrotic syndrome
inferred← citeshttps://doi.org/10.1002/14651858.cd008665openalex-snapshot
Diuretics for treating oedema in nephrotic syndrome
inferred← citeshttps://doi.org/10.1002/2056-4538.70062openalex-snapshot
A membranous nephropathy variant mimicking minimal change disease
inferred← citeshttps://doi.org/10.1002/acr.24738openalex-snapshot
Starting off on the Right Foot: A 22‐Year‐Old Woman With Leg Swelling
inferred← citeshttps://doi.org/10.1002/ccr3.9118openalex-snapshot
Relapsing nephrotic syndrome with acute renal failure following a unique episode of multiple bee stings: A case report
inferred← citeshttps://doi.org/10.1002/cm.21861openalex-snapshot
Roles of myosin 1e and the actin cytoskeleton in kidney functions and familial kidney disease
inferred← citeshttps://doi.org/10.1002/cpdd.879openalex-snapshot
A Review on Drug‐Induced Nephrotoxicity: Pathophysiological Mechanisms, Drug Classes, Clinical Management, and Recent Advances in Mathematical Modeling and Simulation Approaches
inferred← citeshttps://doi.org/10.1002/jcp.30374openalex-snapshot
MicroRNAs in childhood nephrotic syndrome
inferred← citeshttps://doi.org/10.1002/kjm2.12719openalex-snapshot
Telitacicept for minimal change disease
inferred← citeshttps://doi.org/10.1002/ncp.10622openalex-snapshot
Pediatric Nephrotic Syndrome: Pharmacologic and Nutrition Management
inferred← citeshttps://doi.org/10.1002/pca.2969openalex-snapshot
The combination of HPLC and biological analysis to determine the quality markers and its structural composition of Eclipta prostrata L.
inferred← citeshttps://doi.org/10.1002/rai2.12126openalex-snapshot
New sights into new‐onset and relapsed minimal change disease post COVID‐19 vaccination: A systemic review of the clinical characteristics and underlying pathogenesis
inferred← citeshttps://doi.org/10.1007/978-3-030-18711-8_7openalex-snapshot
Glomerulopathies in the Elderly
inferred← citeshttps://doi.org/10.1007/978-3-030-43027-6_12openalex-snapshot
Test the Urine: Understanding Haematuria, Proteinuria and Urinary Infection
inferred← citeshttps://doi.org/10.1007/978-3-030-52719-8_24openalex-snapshot
Nephrotic Syndrome: Classification and Evaluation
inferred← citeshttps://doi.org/10.1007/978-3-030-52719-8_92openalex-snapshot
Steroid-Sensitive Nephrotic Syndrome
inferred← citeshttps://doi.org/10.1007/978-3-030-76419-7_18openalex-snapshot
Management of the Nephrotic Patient: The Overall Approach to the Patient with Nephrotic Syndrome
inferred← citeshttps://doi.org/10.1007/978-3-031-66349-9_13openalex-snapshot
Test the Urine: Understanding Haematuria, Proteinuria and Urinary Infection
inferred← citeshttps://doi.org/10.1007/978-3-032-23967-9_13openalex-snapshot
Nonneoplastic Diseases of the Kidney
inferred← citeshttps://doi.org/10.1007/978-3-319-27334-1_5-1openalex-snapshot
Overview of the Current Approach to Glomerular Disease Classification
inferred← citeshttps://doi.org/10.1007/978-3-319-49379-4_5openalex-snapshot
Overview of the Current Approach to Glomerular Disease Classification
inferred← citeshttps://doi.org/10.1007/978-3-642-27843-3_24-3openalex-snapshot
Nephrotic Syndrome: Classification and Evaluation
inferred← citeshttps://doi.org/10.1007/978-3-642-27843-3_92-1openalex-snapshot
Steroid-Sensitive Nephrotic Syndrome
inferred← citeshttps://doi.org/10.1007/978-90-368-2571-9_3openalex-snapshot
Preexistent chronic disorders, often directly affecting pregnancy
inferred← citeshttps://doi.org/10.1007/s00108-026-02102-8openalex-snapshot
Primäre Glomerulonephritiden
inferred← citeshttps://doi.org/10.1007/s00261-022-03780-2openalex-snapshot
Development and validation of a simple-to-use nomogram for predicting minimal change disease based on quantification of color Doppler sonography data from a region of interest
inferred← citeshttps://doi.org/10.1007/s00292-022-01061-9openalex-snapshot
Grundlagen der Nierenpathologie für Pathologen – Teil 1
inferred← citeshttps://doi.org/10.1007/s00292-022-01164-3openalex-snapshot
Elektronenmikroskopie in der Nephropathologie
inferred← citeshttps://doi.org/10.1007/s00424-017-1993-zopenalex-snapshot
Podocytes from the diagnostic and therapeutic point of view
inferred← citeshttps://doi.org/10.1007/s00467-017-3677-5openalex-snapshot
Immunology of idiopathic nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s00467-018-3929-zopenalex-snapshot
Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s00467-018-3963-xopenalex-snapshot
Treating the idiopathic nephrotic syndrome: are steroids the answer?
inferred← citeshttps://doi.org/10.1007/s00467-018-3994-3openalex-snapshot
Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings
inferred← citeshttps://doi.org/10.1007/s00467-018-4095-zopenalex-snapshot
B cell phenotype in pediatric idiopathic nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s00467-018-4127-8openalex-snapshot
Equations to estimate prednisone dose using body weight
inferred← citeshttps://doi.org/10.1007/s00467-020-04541-3openalex-snapshot
Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse
inferred← citeshttps://doi.org/10.1007/s00467-020-04570-yopenalex-snapshot
Rituximab versus cyclophosphamide as first steroid-sparing agent in childhood frequently relapsing and steroid-dependent nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s00467-020-04681-6openalex-snapshot
Value of electron microscopy in the pathological diagnosis of native kidney biopsies in children
inferred← citeshttps://doi.org/10.1007/s00467-020-04811-0openalex-snapshot
A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s00467-020-04867-yopenalex-snapshot
Biomarkers in pediatric glomerulonephritis and nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s00467-021-04983-3openalex-snapshot
Update on the treatment of steroid-sensitive nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s00467-021-05175-9openalex-snapshot
Belimumab for the treatment of children with frequently relapsing nephrotic syndrome: the BELNEPH study
inferred← citeshttps://doi.org/10.1007/s00467-021-05182-wopenalex-snapshot
The causes and consequences of paediatric kidney disease on adult nephrology care
inferred← citeshttps://doi.org/10.1007/s00467-021-05273-8openalex-snapshot
Circulating plasmablasts in children with steroid-sensitive nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s00467-022-05739-3openalex-snapshot
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s00467-022-05783-zopenalex-snapshot
Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study
inferred← citeshttps://doi.org/10.1007/s00467-022-05824-7openalex-snapshot
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice
inferred← citeshttps://doi.org/10.1007/s00467-024-06447-wopenalex-snapshot
To biopsy or not to biopsy a teenager with typical idiopathic nephrotic syndrome? Start steroids first
inferred← citeshttps://doi.org/10.1007/s00467-024-06510-6openalex-snapshot
To biopsy or not to biopsy a teenager with idiopathic nephrotic syndrome? Biopsy first
inferred← citeshttps://doi.org/10.1007/s00467-025-06750-0openalex-snapshot
The interplay between the cardiovascular system and pediatric congenital or acquired kidney diseases
inferred← citeshttps://doi.org/10.1007/s00467-026-07175-zopenalex-snapshot
Single-dose versus multi-dose steroid therapy in pediatric nephrotic syndrome: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s00467-026-07192-yopenalex-snapshot
Treatment outcomes and ongoing pediatric trials in steroid-resistant nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s00467-026-07292-9openalex-snapshot
Anti-nephrin antibodies in pediatric nephrotic syndrome: a new paradigm
inferred← citeshttps://doi.org/10.1007/s00467-026-07529-7openalex-snapshot
Can urinary albumin-creatinine ratio be used as a surrogate for protein-creatinine ratio in the diagnosis and management of pediatric steroid sensitive nephrotic syndrome?
inferred← citeshttps://doi.org/10.1007/s00508-023-02258-5openalex-snapshot
Diagnostik und Therapie der Minimal Change Glomerulopathie beim Erwachsenen – 2023
inferred← citeshttps://doi.org/10.1007/s10157-017-1489-3openalex-snapshot
Interaction of CD80 with Neph1: a potential mechanism of podocyte injury
inferred← citeshttps://doi.org/10.1007/s10157-020-01985-7openalex-snapshot
Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome
inferred← citeshttps://doi.org/10.1007/s10157-021-02119-3openalex-snapshot
Association of initial prednisolone dose with remission, relapse, and infectious complications in adult-onset minimal change disease
inferred← citeshttps://doi.org/10.1007/s10157-023-02449-4openalex-snapshot
Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study
inferred← citeshttps://doi.org/10.1007/s10157-024-02526-2openalex-snapshot
Estimating baseline creatinine levels based on the kidney parenchymal volume
inferred← citeshttps://doi.org/10.1007/s10157-025-02704-wopenalex-snapshot
Serum matrix metalloproteinase-9 as a predictor of recurrence in idiopathic nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s10157-026-02923-9openalex-snapshot
Energy metabolism in the kidney and its role in chronic kidney disease
inferred← citeshttps://doi.org/10.1007/s10396-024-01455-7openalex-snapshot
Effect of proteinuria at relapse on shear wave velocity assessed using ultrasound elastography in children with idiopathic nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s10528-024-10883-6openalex-snapshot
Association of PLCE1 (rs7922612) and COL4A3 (rs375290088) Genetic Variants with the Risk of Nephrotic Syndrome in Egyptian Pediatric Patients
inferred← citeshttps://doi.org/10.1007/s11255-021-02889-5openalex-snapshot
Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report
inferred← citeshttps://doi.org/10.1007/s11255-022-03382-3openalex-snapshot
Demographic, clinical and laboratory characteristics of adult-onset minimal change disease in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group
inferred← citeshttps://doi.org/10.1007/s11255-024-04226-yopenalex-snapshot
Screening core genes for minimal change disease based on bioinformatics and machine learning approaches
inferred← citeshttps://doi.org/10.1007/s11255-025-04537-8openalex-snapshot
Dental caries prevention as a modifiable precipitating factor of nephrotic syndrome relapse in children: an insight into simple-novel management
inferred← citeshttps://doi.org/10.1007/s12010-023-04333-zopenalex-snapshot
Minnelide Markedly Reduces Proteinuria in Mice with Adriamycin Nephropathy by Protecting Against Podocyte Injury
inferred← citeshttps://doi.org/10.1007/s12098-026-06132-wopenalex-snapshot
Nephrotic Syndrome: Current Management
inferred← citeshttps://doi.org/10.1007/s13340-026-00909-2openalex-snapshot
Minimal change disease in a patient with type 1 diabetes and Crohn’s disease managed with advanced hybrid closed-loop insulin therapy during corticosteroid treatment
inferred← citeshttps://doi.org/10.1007/s13730-017-0282-1openalex-snapshot
Relapse of nephrotic syndrome triggered by Kawasaki disease
inferred← citeshttps://doi.org/10.1007/s13730-020-00554-xopenalex-snapshot
Spontaneous remission of minimal change nephrotic syndrome in an elderly man
inferred← citeshttps://doi.org/10.1007/s13730-020-00568-5openalex-snapshot
A case of minimal change nephrotic syndrome with pregnancy
inferred← citeshttps://doi.org/10.1007/s13730-022-00702-5openalex-snapshot
A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose
inferred← citeshttps://doi.org/10.1007/s13730-023-00798-3openalex-snapshot
Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review
inferred← citeshttps://doi.org/10.1007/s13730-024-00935-6openalex-snapshot
Effective calcineurin inhibitor treatment in adult-onset steroid-resistant nephrotic syndrome with a novel splice donor site variant of TRPC6: a case report
inferred← citeshttps://doi.org/10.1007/s13730-025-00986-3openalex-snapshot
A case of acute appendicitis in a patient with minimal change disease
inferred← citeshttps://doi.org/10.1007/s13730-025-01087-xopenalex-snapshot
A case report of spontaneous remission and relapse in minimal change disease: a heterogeneous disease entity
inferred← citeshttps://doi.org/10.1007/s13730-026-01144-zopenalex-snapshot
Nephrin–IgG co-localization expression in pediatric steroid-resistant nephrotic syndrome: a case series from Indonesia
inferred← citeshttps://doi.org/10.1007/s40124-018-0183-6openalex-snapshot
Recent Advances in Genetic Aspects and Treatments for Steroid-Sensitive Nephrotic Syndrome in Children
inferred← citeshttps://doi.org/10.1007/s40620-017-0464-0openalex-snapshot
Monoclonal B lymphocytosis and minimal change disease: a new monoclonal B-cell disorder of renal significance?
inferred← citeshttps://doi.org/10.1007/s40620-021-01111-0openalex-snapshot
Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndrome
inferred← citeshttps://doi.org/10.1007/s40620-022-01279-zopenalex-snapshot
Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study
inferred← citeshttps://doi.org/10.1007/s40620-023-01710-zopenalex-snapshot
Nephrotic syndrome following COVID-19 vaccination: a systematic review
inferred← citeshttps://doi.org/10.1007/s40620-024-02084-6openalex-snapshot
Minimal change glomerular disease associated with solid neoplasms: a systematic review
inferred← citeshttps://doi.org/10.1007/s40746-024-00309-1openalex-snapshot
Evaluation and Management of Proteinuria in Children
inferred← citeshttps://doi.org/10.1016/b978-0-12-815389-5.00051-4openalex-snapshot
Glomerular disorders
inferred← citeshttps://doi.org/10.1016/b978-0-323-66165-2.00010-7openalex-snapshot
Ureter, Urinary Bladder, and Kidney
inferred← citeshttps://doi.org/10.1016/b978-0-443-19200-5.00009-9openalex-snapshot
Anti-CD20 antibodies in glomerular diseases, their resistance and reversal approaches
inferred← citeshttps://doi.org/10.1016/b978-0-443-23947-2.00076-xopenalex-snapshot
Autoimmune diseases of the kidney
inferred← citeshttps://doi.org/10.1016/b978-0-443-33090-2.00018-7openalex-snapshot
Minimal change disease: current trends and therapeutic options
inferred← citeshttps://doi.org/10.1016/b978-2-294-76353-3.00030-3openalex-snapshot
Épidémiologie et physiopathologie du syndrome néphrotique idiopathique
inferred← citeshttps://doi.org/10.1016/b978-2-294-76353-3.00031-5openalex-snapshot
Syndrome néphrotique corticosensible
inferred← citeshttps://doi.org/10.1016/b978-3-437-21335-9.00033-6openalex-snapshot
Alter schützt vor… nicht!
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2020.01.008openalex-snapshot
Autophagy in kidney disease: Advances and therapeutic potential
inferred← citeshttps://doi.org/10.1016/j.amjms.2019.01.017openalex-snapshot
Soluble Vascular Cell Adhesion Molecule-1 Is Associated With Disease Activity in Adult-Onset Minimal Change Disease
inferred← citeshttps://doi.org/10.1016/j.amjms.2023.03.011openalex-snapshot
Cerebral venous thrombosis in an adult with relapsing minimal change disease
inferred← citeshttps://doi.org/10.1016/j.amjms.2025.01.002openalex-snapshot
Unexpected renal side effects of mRNA COVID-19 vaccines; a single-center experience and short review
inferred← citeshttps://doi.org/10.1016/j.artmed.2023.102720openalex-snapshot
GCLR: A self-supervised representation learning pretext task for glomerular filtration barrier segmentation in TEM images
inferred← citeshttps://doi.org/10.1016/j.atherosclerosissup.2019.08.027openalex-snapshot
Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here?
inferred← citeshttps://doi.org/10.1016/j.autrev.2018.04.007openalex-snapshot
Does cyclophosphamide still play a role in glomerular diseases?
inferred← citeshttps://doi.org/10.1016/j.autrev.2020.102671openalex-snapshot
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
inferred← citeshttps://doi.org/10.1016/j.bbadis.2025.167660openalex-snapshot
Ubiquitin-specific peptidase 10 promotes renal interstitial fibrosis progression through deubiquitinating and stabilizing P53 protein
inferred← citeshttps://doi.org/10.1016/j.bbrep.2021.101102openalex-snapshot
Urinary and plasma proteomics to discover biomarkers for diagnosing between diabetic nephropathy and minimal change nephrotic syndrome or membranous nephropathy
inferred← citeshttps://doi.org/10.1016/j.crbiot.2021.05.007openalex-snapshot
Current Therapies in Nephrotic Syndrome: HDAC inhibitors, an Emerging Therapy for Kidney Diseases
inferred← citeshttps://doi.org/10.1016/j.ecoenv.2024.116593openalex-snapshot
Air quality and kidney health: Assessing the effects of PM10, PM2.5, CO, and NO2 on renal function in primary glomerulonephritis
inferred← citeshttps://doi.org/10.1016/j.ejphar.2019.04.023openalex-snapshot
Therapeutic and antiproteinuric effects of salvianolic acid A in combined with low-dose prednisone in minimal change disease rats: Involvement of PPARγ/Angptl4 and Nrf2/HO-1 pathways
inferred← citeshttps://doi.org/10.1016/j.ekir.2018.02.011openalex-snapshot
Effect of Combined Gluten-Free, Dairy-Free Diet in Children With Steroid-Resistant Nephrotic Syndrome: An Open Pilot Trial
inferred← citeshttps://doi.org/10.1016/j.ekir.2020.10.033openalex-snapshot
A National Registry Study of Patient and Renal Survival in Adult Nephrotic Syndrome
inferred← citeshttps://doi.org/10.1016/j.ekir.2021.04.029openalex-snapshot
Apheresis in Adult With Refractory Idiopathic Nephrotic Syndrome on Native Kidneys
inferred← citeshttps://doi.org/10.1016/j.ekir.2021.11.037openalex-snapshot
Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation
inferred← citeshttps://doi.org/10.1016/j.ekir.2022.03.001openalex-snapshot
Minimal Change Disease: More Than a Podocytopathy?
inferred← citeshttps://doi.org/10.1016/j.ekir.2022.04.006openalex-snapshot
Serum Protein Signatures Using Aptamer-Based Proteomics for Minimal Change Disease and Membranous Nephropathy
inferred← citeshttps://doi.org/10.1016/j.ekir.2023.02.1070openalex-snapshot
Rituximab as Initial Therapy in Adult Patients With Minimal Change Disease
inferred← citeshttps://doi.org/10.1016/j.ekir.2023.05.018openalex-snapshot
Common Risk Variants in AHI1 Are Associated With Childhood Steroid Sensitive Nephrotic Syndrome
inferred← citeshttps://doi.org/10.1016/j.ekir.2023.05.021openalex-snapshot
Implementation and Feasibility of Clinical Genome Sequencing Embedded Into the Outpatient Nephrology Care for Patients With Proteinuric Kidney Disease
inferred← citeshttps://doi.org/10.1016/j.ekir.2024.02.006openalex-snapshot
Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis
inferred← citeshttps://doi.org/10.1016/j.ekir.2024.05.003openalex-snapshot
Clinical Characteristics of Nephrin Autoantibody-Positive Minimal Change Disease in Older Adults
inferred← citeshttps://doi.org/10.1016/j.ekir.2026.103794openalex-snapshot
Effect of Steroids on Anti-nephrin Autoantibodies and B cells in Minimal Change Disease
inferred← citeshttps://doi.org/10.1016/j.ekir.2026.107014openalex-snapshot
Single-Nucleus Transcriptomic Atlas Reveals Disease-Associated Cellular States in Human Glomerular Diseases
inferred← citeshttps://doi.org/10.1016/j.gene.2026.150043openalex-snapshot
Differential early tubular injury in minimal Change disease and Focal segmental Glomerulosclerosis: A Multifaceted analysis
inferred← citeshttps://doi.org/10.1016/j.idcr.2021.e01236openalex-snapshot
Minimal change disease and subacute interstitial nephritis in association with Edwardsiella tarda gastroenteritis following oyster consumption
inferred← citeshttps://doi.org/10.1016/j.imlet.2017.11.002openalex-snapshot
FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome
inferred← citeshttps://doi.org/10.1016/j.imlet.2021.07.006openalex-snapshot
The disturbance and clinical significance of B cell and circulating follicular helper T cell subsets in children with primary nephrotic syndrome
inferred← citeshttps://doi.org/10.1016/j.imlet.2022.06.003openalex-snapshot
Potential contribution of the immune system to the emergence of renal diseases
inferred← citeshttps://doi.org/10.1016/j.intimp.2022.109493openalex-snapshot
Contribution of IL-33/ILC2-mediated Th2 cytokines during the progression of minimal change disease
inferred← citeshttps://doi.org/10.1016/j.intimp.2022.109656openalex-snapshot
Minnelide combined with Angptl3 knockout completely protects mice with adriamycin nephropathy via suppression of TGF-β1-Smad2 and p53 pathways
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.110589openalex-snapshot
The kinetics of mTORC1 activation associates with FOXP3 expression pattern of CD4+ T cells and outcome of steroid-sensitive minimal change disease
inferred← citeshttps://doi.org/10.1016/j.isci.2022.104694openalex-snapshot
Pulmonary surfactants and the respiratory-renal connection in steroid-sensitive nephrotic syndrome of childhood
inferred← citeshttps://doi.org/10.1016/j.jaut.2017.12.014openalex-snapshot
Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice
inferred← citeshttps://doi.org/10.1016/j.jcyt.2017.12.001openalex-snapshot
Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome
inferred← citeshttps://doi.org/10.1016/j.jep.2021.114351openalex-snapshot
Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition
inferred← citeshttps://doi.org/10.1016/j.jfma.2024.06.013openalex-snapshot
Ultra-low-dose rituximab is effective for the treatment of patients with minimal change disease - A retrospective study
inferred← citeshttps://doi.org/10.1016/j.jrras.2023.100625openalex-snapshot
Value of ultrasound imaging-omics features in the diagnosis of primary nephrotic syndrome
inferred← citeshttps://doi.org/10.1016/j.jtcms.2022.01.003openalex-snapshot
Effects of Qidi Tangshen granules and their separate prescriptions on podocytes in mice with diabetic nephropathy
inferred← citeshttps://doi.org/10.1016/j.jtemb.2019.01.008openalex-snapshot
Sub-acute oral exposure of zinc oxide nanoparticles causes alteration in iron homeostasis through acute phase response: A protective effect by surface modification
inferred← citeshttps://doi.org/10.1016/j.kint.2017.12.028openalex-snapshot
Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases
inferred← citeshttps://doi.org/10.1016/j.kint.2018.11.008openalex-snapshot
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
inferred← citeshttps://doi.org/10.1016/j.kint.2019.04.006openalex-snapshot
Atypical IgM on T cells predict relapse and steroid dependence in idiopathic nephrotic syndrome
inferred← citeshttps://doi.org/10.1016/j.kint.2019.04.028openalex-snapshot
Glomerular C4d deposition can precede the development of focal segmental glomerulosclerosis
inferred← citeshttps://doi.org/10.1016/j.kint.2020.09.024openalex-snapshot
Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children
inferred← citeshttps://doi.org/10.1016/j.kint.2021.04.033openalex-snapshot
Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
inferred← citeshttps://doi.org/10.1016/j.kint.2021.05.007openalex-snapshot
Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
inferred← citeshttps://doi.org/10.1016/j.kint.2021.05.021openalex-snapshot
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
inferred← citeshttps://doi.org/10.1016/j.kint.2022.01.036openalex-snapshot
The calcium-sensing receptor stabilizes podocyte function in proteinuric humans and mice
inferred← citeshttps://doi.org/10.1016/j.kint.2022.10.029openalex-snapshot
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management
inferred← citeshttps://doi.org/10.1016/j.kint.2024.01.011openalex-snapshot
Glutamyl-prolyl-tRNA synthetase (EPRS1) drives tubulointerstitial nephritis-induced fibrosis by enhancing T cell proliferation and activity
inferred← citeshttps://doi.org/10.1016/j.kint.2024.11.007openalex-snapshot
KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children
inferred← citeshttps://doi.org/10.1016/j.labinv.2025.106064openalex-snapshot
Identification of Potential Focal Segmental Glomerulosclerosis (FSGS) Through Evaluation of Parietal Epithelial Cells Status Changes Using Integrin α3 Immunostaining
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119463openalex-snapshot
Roles of microRNAs in renal disorders related to primary podocyte dysfunction
inferred← citeshttps://doi.org/10.1016/j.matpr.2021.07.170openalex-snapshot
Estimation of insulin like growth Factor-1 (IGF-1) and other biochemical parameters in nephropathy patients
inferred← citeshttps://doi.org/10.1016/j.molimm.2017.12.020openalex-snapshot
Increased PD-1+CD154+ Tfh cells are possibly the most important functional subset of PD-1+ T follicular helper cells in adult patients with minimal change disease
inferred← citeshttps://doi.org/10.1016/j.molimm.2019.07.001openalex-snapshot
Circulating follicular T helper cells are possibly associated with low levels of serum immunoglobulin G due to impaired immunoglobulin class-switch recombination of B cells in children with primary nephrotic syndrome
inferred← citeshttps://doi.org/10.1016/j.mpdhp.2021.01.005openalex-snapshot
Minimal change disease complicated by contrast-induced nephropathy
inferred← citeshttps://doi.org/10.1016/j.nefro.2022.11.004openalex-snapshot
β1-Integrin blockade prevents podocyte injury in experimental models of minimal change disease
inferred← citeshttps://doi.org/10.1016/j.nefroe.2023.04.003openalex-snapshot
β1-Integrin blockade prevents podocyte injury in experimental models of minimal change disease
inferred← citeshttps://doi.org/10.1016/j.nephro.2022.04.003openalex-snapshot
Tacrolimus treatment after short-term intravenous methylprednisolone in incipient minimal change disease for adults: A retrospective analysis
inferred← citeshttps://doi.org/10.1016/j.nursi.2019.09.006openalex-snapshot
Nefropatía de cambios mínimos Un caso clínico
inferred← citeshttps://doi.org/10.1016/j.phyplu.2025.100844openalex-snapshot
Comprehensive regulation of Danggui-Shaoyao-San and its active constituent PGG on puromycin aminonucleoside induced nephrotic syndrome in rats
inferred← citeshttps://doi.org/10.1016/j.therap.2023.10.010openalex-snapshot
Drug-induced glomerular diseases
inferred← citeshttps://doi.org/10.1016/j.trsl.2026.01.002openalex-snapshot
B-cell activation underpins Rituximab response in focal segmental glomerulosclerosis
inferred← citeshttps://doi.org/10.1016/j.xkme.2025.101049openalex-snapshot
Effects of Podocyte Foot Process Effacement on Kidney Prognosis and Response to Immunosuppressive Therapy in IgA Nephropathy
inferred← citeshttps://doi.org/10.1016/j.xkme.2025.101057openalex-snapshot
Obinutuzumab, an Anti-CD20, in Refractory Adult Autoimmune Podocytopathies: Report of 2 Cases
inferred← citeshttps://doi.org/10.1016/j.xkme.2026.101452openalex-snapshot
Pandemic-Related Reductions in Respiratory Infections and New-Onset Nephrotic Syndrome: A Multicenter Cohort Study in Japan
inferred← citeshttps://doi.org/10.1016/s0140-6736(18)30536-1openalex-snapshot
Idiopathic nephrotic syndrome in children
inferred← citeshttps://doi.org/10.1016/s0140-6736(23)01051-6openalex-snapshot
Childhood nephrotic syndrome
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c00680openalex-snapshot
Profound Changes in Functional Structure and Dynamics of Serum Albumin in Children with Nephrotic Syndrome: An Exploratory Research Study
inferred← citeshttps://doi.org/10.1024/1661-8157/a003223openalex-snapshot
CME: Das nephrotische Syndrom beim Erwachsenen: Präsentation, Abklärung, Therapie
inferred← citeshttps://doi.org/10.1038/s41419-023-06124-0openalex-snapshot
Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis
inferred← citeshttps://doi.org/10.1038/s41581-018-0074-7openalex-snapshot
Effector and regulatory B cells in immune-mediated kidney disease
inferred← citeshttps://doi.org/10.1038/s41581-019-0217-5openalex-snapshot
Molecular stratification of idiopathic nephrotic syndrome
inferred← citeshttps://doi.org/10.1038/s41581-023-00741-wopenalex-snapshot
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
inferred← citeshttps://doi.org/10.1038/s41581-024-00815-3openalex-snapshot
Role of biophysics and mechanobiology in podocyte physiology
inferred← citeshttps://doi.org/10.1038/s41598-019-42905-4openalex-snapshot
The relationship between thyroid dysfunction and nephrotic syndrome: a clinicopathological study
inferred← citeshttps://doi.org/10.1038/s41598-021-86109-1openalex-snapshot
Metformin ameliorates the severity of experimental Alport syndrome
inferred← citeshttps://doi.org/10.1038/s41598-021-92573-6openalex-snapshot
The immune cell landscape of peripheral blood mononuclear cells from PNS patients
inferred← citeshttps://doi.org/10.1038/s41598-023-32576-7openalex-snapshot
Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS
inferred← citeshttps://doi.org/10.1038/s41598-023-39893-xopenalex-snapshot
The influence of calcitriol and methylprednisolone on podocytes function in minimal change disease in vitro model
inferred← citeshttps://doi.org/10.1038/s41598-023-45678-zopenalex-snapshot
Exploring the significance of interleukin-33/ST2 axis in minimal change disease
inferred← citeshttps://doi.org/10.1038/s41598-023-49861-0openalex-snapshot
Evaluation of glomerular sirtuin-1 and claudin-1 in the pathophysiology of nondiabetic focal segmental glomerulosclerosis
inferred← citeshttps://doi.org/10.1038/s41598-024-68406-7openalex-snapshot
Investigating quantitative histological characteristics in renal pathology using HistoLens
inferred← citeshttps://doi.org/10.1038/s41598-024-68837-2openalex-snapshot
Rare heterozygous variants in paediatric steroid resistant nephrotic syndrome – a population-based analysis of their significance
inferred← citeshttps://doi.org/10.1038/s41598-025-19214-0openalex-snapshot
Rituximab-induced long-term remission in childhood-onset, uncomplicated, frequently relapsing or steroid-dependent nephrotic syndrome: a randomized, placebo-controlled trial and a follow-up study
inferred← citeshttps://doi.org/10.1038/s41598-025-23393-1openalex-snapshot
A CPEB2/ANGPTL3 feedback loop promotes the progression of podocyte injury in nephrotic syndrome
inferred← citeshttps://doi.org/10.1038/s41598-025-96125-0openalex-snapshot
Systemic inflammation accelerates the development of focal segmental glomerulosclerosis in a mouse model of adriamycin induced nephrosis
showing the first 200 of 552 · page through all 552
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.